InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Muhbruh Free
10/10/24 2:37 PM
Bullish
Bullish
profile icon
tw0122 Free
09/19/24 10:13 AM
profile icon
TheFinalCD PremiumMember
09/19/24 7:36 AM
profile icon
tw0122 Free
09/19/24 4:20 AM
profile icon
TheFinalCD PremiumMember
09/18/24 8:50 PM
profile icon
TrendTrade2016 Free
09/17/24 2:02 PM
profile icon
TrendTrade2016 Free
09/17/24 1:59 PM
profile icon
TrendTrade2016 Free
09/17/24 1:54 PM
profile icon
TrendTrade2016 Free
09/17/24 1:42 PM
profile icon
JMoneyHoops Free
09/17/24 11:16 AM
profile icon
TrendTrade2016 Free
09/16/24 3:39 PM
profile icon
TrendTrade2016 Free
09/16/24 2:41 PM
profile icon
TrendTrade2016 Free
09/05/24 5:24 AM
profile icon
TrendTrade2016 Free
08/30/24 11:12 AM
profile icon
tw0122 Free
06/18/24 7:19 AM
profile icon
glenn1919 PremiumMember
06/17/24 8:19 PM
profile icon
CanItBThisEZ2Make PremiumMember
05/21/24 12:57 PM
Bullish
Bullish
profile icon
TheFinalCD PremiumMember
01/11/24 7:18 PM
profile icon
OffTheGrid Free
12/05/23 7:36 PM
profile icon
Monksdream PremiumMember
10/22/23 1:07 PM
profile icon
Monksdream PremiumMember
10/02/23 1:37 PM
profile icon
Monksdream PremiumMember
09/21/23 2:41 PM
profile icon
Triple nickle Free
06/09/23 3:39 PM
profile icon
The Night Stalker Free
06/09/23 12:25 PM
profile icon
The Night Stalker Free
06/09/23 12:25 PM
profile icon
Invest-in-America Free
06/09/23 10:11 AM
Bullish
Bullish
profile icon
Triple nickle Free
06/09/23 8:26 AM
profile icon
alchemytrader Free
04/08/23 11:41 PM
profile icon
TheFinalCD PremiumMember
03/28/23 8:26 AM
profile icon
zj3001 Free
03/28/23 8:14 AM
profile icon
alchemytrader Free
03/28/23 7:54 AM
Bearish
Bearish
profile icon
harry crumb Free
01/31/23 8:46 AM
profile icon
harry crumb Free
01/25/23 6:56 PM
profile icon
Toddrobertking Free
01/25/23 6:23 PM
profile icon
harry crumb Free
01/25/23 11:10 AM
profile icon
harry crumb Free
01/25/23 10:58 AM
profile icon
TheFinalCD PremiumMember
01/25/23 10:29 AM
profile icon
TheFinalCD PremiumMember
01/25/23 9:48 AM
profile icon
resx18 PremiumMember
01/25/23 9:19 AM
profile icon
TheFinalCD PremiumMember
01/25/23 8:53 AM
Bullish
Bullish
profile icon
TheFinalCD PremiumMember
01/25/23 8:39 AM
Bullish
Bullish
profile icon
TheFinalCD PremiumMember
01/25/23 8:32 AM
Bullish
Bullish

Sonoma Pharmaceuticals (snoa) RSS Feed

Followers
11
Posters
55
Posts (Today)
0
Posts (Total)
158
Created
08/14/17
Type
Free
Moderators

SNOA (MC $23 M)(Cash $13 M) Shares Out 4.3 M / Lots of Marketed Products some of them are in early launch phase plus additional Product launches expected within 6 months / Revenue close to hit $16 million/Profitability expected in 2018 . This undiscovered and revenue generating company is one if not the cheapest pharma you can get at this time .This Stock looking fantastic on all fronts it has a terrible low valuation of $23 Million is well financed with around $13 million and has a ultra low O/S of only 4.3 million .

This low float stock has the potential to hit $50 per share (~ $215 Million) within 12-18 months and even then the valuation would be still low . GL



Sonoma Pharma (Nasdaq: SNOA)

Market Cap: 22.1 Million
Cash: $12.6 Million
Price: $5.15

Shares Out : 4.3 Million

Stonegate Capital Partners Updates Coverage on Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) ..October 18, 2017
http://pr.report/78EFCjq0

Presentation
http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf


Fact Sheet
http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf


Driving to commercial EBITDAS breakeven, without dilution

Grow current product portfolio with all sales people

•Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
•Mondoxyne for severe acne –launched late 2015
•Ceramax for skin repair in atopic dermatitis–launched in April 2016
•SebuDerm for seborrhea dermatitis –launched in November 2016

Launch 3 New Products –our product pipeline –one every other quarter

•Launching Loyon–Fall 2017
•Ceramax in foam and gel forms –Q4 2017 & Q1 2018


Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.


With $19.5 Million in Coffers from Asset Sale, Sonoma Pharmaceuticals Sets Sights on Breakeven

http://analysis.secfilings.com/articles/147-with-19-5-million-in-coffers-from-asset-sale-sonoma-pharmaceuticals-sets-sights-on-breakeven


Regulatory Approvals and Clearances

To date, we have obtained 17 clearances from the U.S. Food and Drug Administration, or FDA, that permit us to sell our products as medical devices for Section 510(k) of the Federal Food, Drug and Cosmetic Act in the United States.

Outside the United Sates, we sell products for dermatological and advanced tissue care with a European Conformity marking (known as Conformité Européenne or CE) covering 25 of our products, and various approvals in Central America, China, Southeast Asia, and the Middle East.

----------------------
Hey guys if you own shares of this low float stock then please put a high GTC sell order in like $20 to prevent your shares from being borrowed to short and more important your shares will not be available on the market this is good because this helps the stock to make bigger jumps on good news . Thans and good luck

How to Prevent your Shares Holdings from being Shorted

http://www.contracts-for-difference.com/Borrowing-lending-shares.html

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
snoa Latest News
New Post